MICE WITH HOMOZYGOUS DISRUPTION OF THE MDR2 P-GLYCOPROTEIN GENE - A NOVEL ANIMAL-MODEL FOR STUDIES OF NONSUPPURATIVE INFLAMMATORY CHOLANGITIS AND HEPATOCARCINOGENESIS
Th. Mauad et al., MICE WITH HOMOZYGOUS DISRUPTION OF THE MDR2 P-GLYCOPROTEIN GENE - A NOVEL ANIMAL-MODEL FOR STUDIES OF NONSUPPURATIVE INFLAMMATORY CHOLANGITIS AND HEPATOCARCINOGENESIS, The American journal of pathology, 145(5), 1994, pp. 1237-1245
The mouse mdr2gene (and its human homologue MDR3, also called MDR2) en
codes a P-glycoprotein that is present in high concentration in the bi
le canalicular membrane of hepatocytes. The 129/OlaHsd mice with a hom
ozygous disruption of the mdr2 gene (-/- mice) lack this P-glycoprotei
n in the canalicular membrane. These mice are tenable to secrete phosp
holipids into bile, showing an essential role for the mdr2 P-glycoprot
ein in the transport of phosphatidylcholine across the canalicular mem
brane. The complete absence of phospholipids from bile leads to a hepa
tic disease, which becomes manifest shortly after birth and shows prog
ression to an end stage in the course of 3 months. The liver pathology
is that of a nonsuppurative inflammatory cholangitis with portal infl
ammation and ductular proliferation, consistent with toxic injury of t
he biliary system from bile salts unaccompanied by phospholipids. Thus
, the mdr2 (-/-) mice can serve as an animal model for studying mechan
isms and potential interventions in nonsuppurative inflammatory cholan
gitis (in a generic sense) in human disease, be it congenital or acqui
red. When the mice are 4 to 6 months of age, preneoplastic lesions dev
elop in the liver, progressing to metastatic liver cancer in the termi
nal phase. Tbe mdr2 (-/-) mice therefore also provide a tumor progress
ion model of value for the study of hepatic carcinogenesis. Interestin
gly, also in this regard, the model mimicks human disease, because chr
onic inflammation of the biliary system in humans may similarly carry
increased cancer risk.